10 unknown, 7 completed, 1 recruiting, 1 terminated. 20 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 20 | Unknown 10, Completed 7, Recruiting 1, Terminated 1, Withdrawn 1 |
Follow Baraclude: new trials by email Literature Review of Baraclude trials Research Report on Baraclude
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tenofovir Alafenamide Versus Entecavir for the Treatment of Chronic Hepatitis B Tenofovir alafenamide, Entecavir - Hepatitis B, Viral Hepatitis | Phase 4 | Recruiting | Taichung Veterans General Hospital | 140 | 2019-08-19 | 2026-05-14 |
| Tacrolimus Combined With Entecavir on HBV Associated Glomerulonephritis(HBV-GN) Tacrolimus &entecavir, placebo & entecavir - Hepatitis B Virus Associated Nephrotic Syndrome | Phase 4 | Unknown | Guangdong Provincial People's Hospital | 112 | 2017-02-01 | 2017-02-24 |
| Peginterferon Alfa-2b Treatment in HBeAg(+) Chronic Hepatitis b Patients Based on Interferon Gene Mutation and Receptor Detection Entecavir or Tenofovir, Peginterferon Alfa-2B - Chronic Hepatitis b | Phase 4 | Unknown | Third Affiliated Hospital, Sun Yat-Sen University | 100 | 2016-01-01 | 2016-11-25 |
| Study to Evaluate the Non-inferiority of Cavir in HBeAg(+)Chronic Hepatitis B Patients Treated With Baraclude Cavir, Baraclude - Chronic Hepatitis B | Phase 4 | Unknown | Hanmi Pharmaceutical Company Limited | 134 | 2015-01-01 | 2015-08-14 |
| Entecavir for Biological Agents Associated HBV Reactivation in Inflammatory Arthritis Patients Entecavir - Rheumatoid Arthritis, Hepatitis B Reactivation | Phase 4 | Unknown | Taipei Veterans General Hospital, Taiwan | 115 | 2013-09-10 | 2019-03-13 |
| Prophylactic Use of Entecavir for HBsAg Negative/HBcAb Positive/Hepatitis B Virus DNA Negative Patients With Lymphoma Entecavir prophylaxis, Observation arm - Hepatitis B | Phase 4 | Unknown | Peking University | 190 | 2013-01-01 | 2017-01-10 |
| Prophylactic Use of Entecavir for HBsAg Positive Lymphoma Patients Treated With Rituximab-based Immunochemotherapy Entecavir prophylaxis - Hepatitis B | Phase 4 | Unknown | Peking University | 80 | 2013-01-01 | 2017-01-10 |
| Tenofovir vs. Tenofovir Plus Entecavir in Entecavir-Resistant Chronic Hepatitis B Tenofovir, Entecavir - Chronic Viral Hepatitis B Without Delta-agent | Phase 4 | Completed | Asan Medical Center | 88 | 2012-09-28 | 2018-05-09 |
| Tenofovir Plus Entecavir vs. Tenofovir in Adefovir-Resistant Chronic Hepatitis B Tenofovir, Entecavir - Chronic Viral Hepatitis B Without Delta-agent | Phase 4 | Completed | Asan Medical Center | 102 | 2012-09-25 | 2018-02-20 |
| Antiviral Efficacy of Switching to ETV Plus TDF Group A (Zeffix, Sebivo, Hepsera), Group B (Baraclude, Viread) - Chronic Hepatitis B | Phase 4 | Unknown | Yonsei University | 104 | 2012-08-01 | 2014-01-31 |
| Efficacy of Telbivudine With or Without add-on Tenofovir According to Roadmap Strategy Compare With Entecavir Telbivudine, Tenofovir, Entecavir - Chronic Hepatitis B | Phase 4 | Unknown | Pusan National University Yangsan Hospital | 104 | 2012-04-01 | 2012-05-02 |
| Combination or Sequential Therapy of Peginterferon Alfa-2a and Entecavir for Patients With Chronic Hepatitis B Peg-IFNα-2a, Entecavir - Chronic Hepatitis B | Phase 4 | Unknown | Beijing 302 Hospital | 105 | 2011-07-01 | 2015-08-17 |
| Entecavir Plus Adefovir in Lamivudine-Resistant Patients Lamivudine, Entecavir, Adefovir - Hepatitis B, Chronic | Phase 4 | Withdrawn | Bristol-Myers Squibb | 2009-12-01 | 2015-09-01 | |
| Augmenting Response to Entecavir With Peginterferon a-2a for the Treatment of HBeAg-positive Chronic Hepatitis B pegylated interferon a-2a, Entecavir - Chronic Hepatitis B | Phase 4 | Completed | Foundation for Liver Research | 184 | 2009-08-01 | 2014-03-28 |
| A Study to Compare and Evaluate Intrahepatic cccDNA Reduction After Administrating Clevudine or Entecavir in the Chronic HBV Patients Clevudine, Entecavir - Chronic Hepatitis B | Phase 4 | Terminated | Bukwang Pharmaceutical | 75 | 2009-08-01 | 2014-12-18 |
| Prophylactic Use of Entecavir for Non-Hodgkin's Lymphoma Patients With Resolved Hepatitis B Entecavir prophylaxis, Therapeutic entecavir - Non Hodgkin's Lymphoma, Hepatitis B | Phase 4 | Completed | Taipei Veterans General Hospital, Taiwan | 80 | 2009-04-01 | 2013-05-29 |
| Suboptimal Responders to Adefovir Switching to Entecavir Entecavir, Adefovir/Entecavir - Hepatitis B, Chronic | Phase 4 | Completed | Bristol-Myers Squibb | 228 | 2008-07-01 | 2013-02-11 |
| Entecavir for Patients With Decompensated Hepatitis B Virus (HBV)-Related Cirrhosis Entecavir - Hepatitis B Virus, Decompensated Cirrhosis | Phase 4 | Unknown | Shanghai Changzheng Hospital | 200 | 2008-01-01 | 2008-04-23 |
| A Study in Korea of Entecavir Versus Lamivudine in Adults With Chronic Hepatitis B Infection Entecavir, Lamivudine Placebo, Lamivudine - Chronic Hepatitis B | Phase 4 | Completed | Bristol-Myers Squibb | 122 | 2007-02-01 | 2014-11-26 |
| Effect of Entecavir in Blacks/African Americans and Hispanics With Chronic Hepatitis B Virus (HBV) Infection Entecavir - Hepatitis B Infection | Phase 4 | Completed | Bristol-Myers Squibb | 131 | 2006-11-01 | 2012-04-16 |
Hepatitis B, Chronic (10) · Hepatitis B (7) · Lymphoma (3) · Arthritis, Rheumatoid (1) · Fibrosis (1) · Glomerulonephritis, Membranous (1) · Lymphoma, Non-Hodgkin (1)
Bristol-Myers Squibb (4) · Asan Medical Center (2) · Peking University (2) · Taipei Veterans General Hospital, Taiwan (2) · Beijing 302 Hospital (1) · Bukwang Pharmaceutical (1) · Foundation for Liver Research (1) · Guangdong Provincial People's Hospital (1) · Hanmi Pharmaceutical Company Limited (1) · Pusan National University Yangsan Hospital (1) · Shanghai Changzheng Hospital (1) · Taichung Veterans General Hospital (1) · Third Affiliated Hospital, Sun Yat-Sen University (1) · Yonsei University (1)
China (8) · South Korea (6) · Taiwan (3) · Brazil (1) · Mexico (1) · Netherlands (1) · Poland (1) · Puerto Rico (1) · Romania (1) · South Africa (1) · Turkey (Türkiye) (1) · United States (1)
Jun Zhu (2) · Fu-Sheng Wang, Professor (1) · Jian Shi, MD (1) · Ki Tae Yoon, M.D. (1) · Liang Peng, Doctor (1) · Lifen Wang, PHD (1) · Lixia Xu, PHD (1) · Sang Hoon Ahn, MD, PhD (1) · Teng-Yu Lee, MD, PhD (1) · Wei Shi, PHD (1) · Xinling Liang, PHD (1) · Yi-Hsiang Huang, MD, Ph.D. (1) · Yi-Hsiang Huang, MD, PhD (1)
PMID 30876946, PMID 10613747, PMID 15470215, PMID 15565615, PMID 15985009, PMID 16164651, PMID 16525138, PMID 16879891, PMID 17377504, PMID 19052126, PMID 20220333, PMID 2023605, PMID 2142748, PMID 21677438, PMID 22371643, PMID 22668640, PMID 23150796, PMID 23449768, PMID 23689577, PMID 23732715, PMID 23775967, PMID 24189358, PMID 24375637, PMID 25348661, PMID 25476749, PMID 25596179, PMID 25800784, PMID 26389937, PMID 28404091, PMID 28404092, PMID 28427875, PMID 29405329, PMID 29696665, PMID 30689258, PMID 32460460, PMID 35599306, PMID 35672893, PMID 35941076, PMID 757978